This effect has made it popular in skin-whitening treatments
This dehydrogenase reaction occurs in the cytoplasm and requires NAD+ as a cofactor, which is reduced to NADH in the process
Furthermore, being obese or overweight is a significant risk factor, even without weight-loss drugs
Laterza L, Cremon C, Coppola G, Settanni CR, Maresca R, Strazzeri M, et al
Therapeutic Applications Treatments currently approved for commercial use include Liraglutide (Saxenda, Victoza), Semaglutide (Ozempic, Wegovy), and Exenatide (Byetta, Bydureon)
Since GLP-1 medications and this style of eating are primarily associated with weight loss by suppressing appetite, gaining weight for muscle growth requires careful planning to ensure a consistent caloric surplus